Flexible cystoscopy assisted by hexaminolevulinate induced fluorescence: A new approach for bladder cancer detection and surveillance?

European Urology

Volumn 47, Issue 3, 2005, Pages 323-326

  Loidl, W ^a   Schmidbauer, J ^a   Susani, M ^a   Marberger, M ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Bladder cancer; Flexible cystoscopy; Fluorescence cystoscopy; Hexaminolevulinate; Standard cystoscopy

Indexed keywords

AMINOLEVULINIC ACID HEXYL ESTER; DIAGNOSTIC AGENT; LEVULINIC ACID; METHENAMINE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLADDER CANCER; BLUE LIGHT; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CARCINOMA IN SITU; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTOSCOPY; FEMALE; FLUORESCENCE; HUMAN; INTERMETHOD COMPARISON; MALE; PRIORITY JOURNAL; TRANSURETHRAL RESECTION; TUMOR BIOPSY; WHITE LIGHT;

EID: 13844272458     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2004.10.025     Document Type: Article

References (18)

1. H.W. Herr Outpatient flexible cystoscopy and fulguration of recurrent superficial bladder tumors J Urol 144 1990 1365 1366
2. J. Schmidbauer, F. Witjes, N. Schmeller, R. Donat, M. Susani, M. Marberger members of the Hexvix PCB 301/01 Study Group Improved detection of urethelial carcinoma in situ with hexaminolevulinate fluorescence cystoscopy J Urol 171 2004 135 138
3. H.B. Grossman, L.G. Gomella, Y. Fradet, J.C. Presti Jr., Ritenour CWM, and S.P. Lerner The use of Hexvix and fluorescence cystoscopy as an adjunct in the diagnosis of stage Ta/T1 urothelial cancer in the urinary bladder J Urol 171 2004 69
4. L.G. Gomella, H.B. Grossman, J.C. Presti Jr., S.P. Lerner, M.S. Cookson, and D.M. Albala The use of Hexvix and fluorescence cystoscopy as an adjunct in the diagnosis of carcinoma in situ of the urinary bladder J Urol 171 2004 69
5. H.W. Herr Natural history of superficial bladder tumors: 10-to 20-year follow-up of treated patients World J Urol 15 1997 84 88
6. D.L. Lamm Preventing Progression and Improving Survival with BCG Maintenance Eur Urol 37 Suppl 1 2000 9 15
7. L. Cheng, J.C. Cheville, B.C. Leibovich, K.S. Egan, and B.S. Spotts Survival of patients with carcinoma in situ of the urinary bladder Cancer 85 1999 2469 2474
8. E. Solsona, I. Iborra, J.V. Ricos, J.L. Monros, J. Rubio, and S. Almenar Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications J Urol 67 2002 2007 2011
9. C.R. Riedl, D. Daniltchenko, F. Koenig, R. Simak, S.A. Loening, and H. Pflueger Fluorescence endoscopy with 5-aminolevulinic acid reduces early recurrence rate in superficial bladder cancer J Urol 165 2001 1121 1123
10. L.H. Sobin C.H. Wittekind TNM Classification of malignant tumours 6th ed. 2002 Weinheim/Wiley-Liss, Inc. New York
11. J.I. Epstein, M.B. Amin, V.R. Reuter, and F.K. Mostofi The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee Am J Surg Pathol 22 1998 1435 1448
12. K.H. Kurth, C. Bouffioux, R. Sylvester, A.P.M. van der Meijden, W. Oosterlinck, and M. Brausi Treatment of superficial bladder tumors: Achievements and needs Eur Urol 37 2000 1 9
13. R.J. Sylvester, A.P.M. Van der Meijden, and D.L. Lamm Intravesical Bacillus Calmette-Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials J Urol 168 2002 1964 1970
14. D. Zaak, M. Kriegmair, H. Stepp, R. Baumgartner, R. Oberneder, and P. Schneede Endoscopic detection of transitional cell carcinoma with 5-aminolevulinic acid: results of 1012 fluorescence endoscopies Urology 57 2001 690 694
15. T. Filbeck, U. Pichlmeier, R. Knuechel, W.F. Wieland, and W. Roessler Clinically relevant improvement of recurrence-free survival with 5-aminolevulinic acid induced fluorescence diagnosis in patients with superficial bladder tumors J Urol 168 2002 67 71
16. J. Kloek, W. Akkermans, and G.M.J. Beijersbergen van Henegouwen Derivatives of 5-aminolevulinic acid for photodynamic therapy: enzymatic conversion into protoporphyrin Photochemistry and Photobiology 67 1998 150 154
17. A. Marti, N. Lange, H. van den Bergh, D. Sedmera, P. Jichlinski, and P. Kucera Optimalisation of the formation and distribution of protoporphyrin IX in the urothelium: an in vitro approach J Urol 162 1999 546 552
18. D. Zaak, E. Hungerhuber, P. Schneede, H. Stepp, D. Frimberger, and S. Corvin Role of 5-aminolevulinic acid in the detection of urothelial premalignant lesions Cancer 95 2000 1234 1238